Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples